Management of ovarian cancer during the COVID-19 pandemic

Vincenzo Dario Mandato; Lorenzo Aguzzoli

doi:10.1002/ijgo.13167

Management of ovarian cancer during the COVID-19 pandemic

Int J Gynaecol Obstet. 2020 Jun;149(3):382-383. doi: 10.1002/ijgo.13167. Epub 2020 Apr 29.

Authors

Vincenzo Dario Mandato¹, Lorenzo Aguzzoli²

Affiliations

¹ Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.
² Unit of Surgical Gynecological Oncology, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.

Abstract

A new strategy of avoiding ultra‐radical surgery and increasing neoadjuvant therapy for the treatment of ovarian cancer is required during the COVID‐19 pandemic.

Keywords: COVID-19; Neoadjuvant chemotherapy; Ovarian cancer; Upfront surgery.